BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zorzi M, Senore C, Turrin A, Mantellini P, Visioli CB, Naldoni C, Sassoli De' Bianchi P, Fedato C, Anghinoni E, Zappa M, Hassan C; Italian colorectal cancer screening survey group. Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test. Gut 2016;65:1822-8. [PMID: 26297727 DOI: 10.1136/gutjnl-2015-310139] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Dekker E, Chiu HM, Lansdorp-Vogelaar I; WEO Colorectal Cancer Screening Committee. Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era. Gastroenterology 2020;159:1998-2003. [PMID: 32966824 DOI: 10.1053/j.gastro.2020.09.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Symonds EL, Simpson K, Coats M, Chaplin A, Saxty K, Sandford J, Young Am GP, Cock C, Fraser R, Bampton PA. A nurse‐led model at public academic hospitals maintains high adherence to colorectal cancer surveillance guidelines. Medical Journal of Australia 2018;208:492-6. [DOI: 10.5694/mja17.00823] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Jideh B, Bourke MJ. Colorectal cancer screening reduces incidence, mortality and morbidity. Med J Aust. 2018;208:483-484. [PMID: 29902408 DOI: 10.5694/mja18.00279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
4 Forbes N, Hilsden RJ, Martel M, Ruan Y, Dube C, Rostom A, Shorr R, Menard C, Brenner DR, Barkun AN, Heitman SJ. Association Between Time to Colonoscopy After Positive Fecal Testing and Colorectal Cancer Outcomes: A Systematic Review. Clin Gastroenterol Hepatol 2021;19:1344-1354.e8. [PMID: 33010414 DOI: 10.1016/j.cgh.2020.09.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Mangas-sanjuan C, Jover R, Cubiella J, Marzo-castillejo M, Balaguer F, Bessa X, Bujanda L, Bustamante M, Castells A, Diaz-tasende J, Díez-redondo P, Herráiz M, Mascort-roca JJ, Pellisé M, Quintero E. Vigilancia tras resección de pólipos de colon y de cáncer colorrectal. Actualización 2018. Gastroenterología y Hepatología 2019;42:188-201. [DOI: 10.1016/j.gastrohep.2018.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
6 Pohl H. Endoscopy during COVID – what have we learned? Endoscopy 2021;53:171-2. [PMID: 33503667 DOI: 10.1055/a-1327-2386] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Otero I, Burón A, Macià F, Álvarez-Urturi C, Comas M, Román M, Castells X; en nombre del Grupo Procolon. Adherence to follow-up in high-risk adenoma patients diagnosed by, and excluded from the Barcelona colorectal cancer screening programme. Gastroenterol Hepatol 2018;41:226-33. [PMID: 29295752 DOI: 10.1016/j.gastrohep.2017.11.010] [Reference Citation Analysis]
8 Comas M, Mendivil J, Andreu M, Hernández C, Castells X. Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program. PLoS One 2016;11:e0164666. [PMID: 27732635 DOI: 10.1371/journal.pone.0164666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Venturelli F, Ottone M, Pignatti F, Bellocchio E, Pinotti M, Besutti G, Djuric O, Giorgi Rossi P. Using text analysis software to identify determinants of inappropriate clinical question reporting and diagnostic procedure referrals in Reggio Emilia, Italy. BMC Health Serv Res 2021;21:103. [PMID: 33514372 DOI: 10.1186/s12913-021-06093-0] [Reference Citation Analysis]
10 Armelao F, Pertile R, Miori G, Franch R, Avancini I, Meggio A, Franceschini G, Pravadelli C, Tieppo C, Faitini K, Giacomin D, Orlandi PG, Tasini E, de Pretis G. Appropriateness and yield of surveillance colonoscopy in first-degree relatives of colorectal cancer patients: A 5-year follow-up population-based study. Dig Liver Dis 2018;50:475-81. [PMID: 29544764 DOI: 10.1016/j.dld.2018.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Jover R, Dekker E, Schoen RE, Hassan C, Pellise M, Ladabaum U; the WEO Expert Working Group of Surveillance after colonic neoplasm. Colonoscopy quality requisites for selecting surveillance intervals: A World Endoscopy Organization Delphi Recommendation. Digestive Endoscopy 2018;30:750-9. [DOI: 10.1111/den.13229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
12 Aznar-Gimeno R, Carrera-Lasfuentes P, Del-Hoyo-Alonso R, Doblaré M, Lanas Á. Evidence-Based Selection on the Appropriate FIT Cut-Off Point in CRC Screening Programs in the COVID Pandemic. Front Med (Lausanne) 2021;8:712040. [PMID: 34386511 DOI: 10.3389/fmed.2021.712040] [Reference Citation Analysis]
13 Del Vecchio Blanco G, Calabrese E, Biancone L, Monteleone G, Paoluzi OA. The impact of COVID-19 pandemic in the colorectal cancer prevention. Int J Colorectal Dis 2020;35:1951-4. [PMID: 32500432 DOI: 10.1007/s00384-020-03635-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
14 Del Vecchio Blanco G, Dwairi R, Giannelli M, Palmieri G, Formica V, Portarena I, Grasso E, Di Iorio L, Benassi M, Giudice EA, Nardecchia A, Rossi P, Roselli M, Sica G, Monteleone G, Paoluzi OA. Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer. Intern Emerg Med 2021;16:1197-206. [PMID: 33555540 DOI: 10.1007/s11739-020-02565-z] [Reference Citation Analysis]
15 Gallardo-Gómez M, De Chiara L, Álvarez-Chaver P, Cubiella J. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Rev Anticancer Ther 2021;21:723-38. [PMID: 33507120 DOI: 10.1080/14737140.2021.1882858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]